Summary. Serum 
Introduction
The mechanism by which the fetus escapes immunological rejection by the maternal host remains an unsolved mystery. Amongst the several processes which may be involved, suppression of the maternal immune system at the local or systemic level is certain to play a role. Localized uterine immunosuppression in pregnant and progesterone-treated animals has been observed through skin-graft studies (Watnick & Russo, 1968; Beer, Billingham & Scott, 1975) and through demonstration of an immunosuppressive uterine protein (Roberts, 1977; Etzel, Murray, Grifo & Kinder, 1978) . Systemic maternal immunosuppression is supported by studies demonstrating that maternal human (Kasakura, 1971) , bovine (Manak, 1981) and murine (Hellstrom, Hellstrom & Brawn, 1969) plasma suppresses the reactivity to mitogens (Purtilo, Hallgren & Yunis, 1972; Leiken, 1972; Hsu, 1974) .
The role of progesterone in maternal immunosuppression is currently in debate. Progesterone inhibits allograft rejection in vivo (Hulka, Mohr & Lieberman, 1965) and inhibits in-vitro stimulation of human (Clemens, Siiteri & Stites, 1979; Mori et ai, 1975) but not bovine (Murray & Chenault, 1982) lymphocytes. Although concentrations of progesterone are higher in the region of the trophoblast (Clemens et ai, 1979) and in lymphatic fluid (Staples, Fleet & Heap, 1982) than in peripheral blood (1-20 ng/ml), it is not clear whether the level of progesterone at any of these sites is sufficient to produce the immunosuppression observed in vitro (103-104 ng/ml). One possibility is that progesterone influences immune function indirectly rather than directly, by inducing the synthesis of immunomodulatory proteins or glycoproteins (Murray & Chenault, 1982) . Pregnancyspecific glycoproteins have been described (Koch, Morton & Ellendorff, 1983; Sarcione, Delluomo & Zloty, 1983) and glycoprotein synthesis is influenced by oestrogen and progesterone (Nelson, Jato-Rodriguez, Labrie & Mookerjea, 1977; Singh & Lucas, 1981 Lowry, Rosebrough, Farr & Randall (1951) and for sialic acid content by the method of Warren (1959) following hydrolysis with 005 M-H2S04 at 80°C for 1 h and neutralization. Progesterone was determined by radioimmunoassay according to Butcher, Collins & Fugo (1974) as modified by Sheffel, Pratt, Ferrell & Inskeep (1982 RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM-glutamine, 100 units penicillin/ml, 100 µg streptomycin/ml, and 25 mMHepes. Cultures were incubated for 48 h at 37°C in a 5% C02/95% air humidified atmosphere.
[3H]Thymidine (1 µ /eW) was added for the last 8 h of culture. Cells were collected on glass-fibre filters and washed with distilled water using an M-12 cell harvester (Brandel), and 3 ml of Liquiscint were added to each filter in a 7 ml scintillation vial for counting. All cultures were performed in triplicate. Mitogen-stimulated cultures contained a previously determined optimal concentration of phytohaemagglutinin (1-0 µg/ml) or pokeweed mitogen (10 µg/ml) and typical assays contained 5 µ of test or control serum in 200 µ total volume. To calculate immunosuppression, the increase in c.p.m. due to addition of mitogen in the presence of test serum was divided by the increase observed in the absence of serum; this value was subtracted from 1 and the result expressed as %.
Sialyltransferase assay. The assay mixture contained the following concentrations of components in a total volume of 100 µ : 50 mM-Hepes, pH 6-5, 10 mM-MnCL, 0-1% Triton X-100, [l4C]CMP-sialic acid (0-4 mM, 0-6 µ / ), asialofetuin (2-5 mg/ml), and serum (25% v/v (Bazer & First, 1983) . 
Immunosuppressive activity
In preliminary experiments, the duration of incubation ( 1 -6 days) and the concentration of each mitogen (01 to 100 µg/ml) were varied to determine optimal conditions for lymphocyte proliferation. For the current studies a culture time of 2 days was used and concentrations of 1 -0 µg phytohaemagglutinin/ml and 10 µg pokeweed mitogen/ml gave 
Sialic acid content
The average (N = 4) concentration of sialic acid in serum ranged from 1-2 to 1-8 µ / , whereas individual samples ranged from 0-4 to 2-3 µ /ml. These concentrations are similar to those reported for human serum, for which the upper limit of normal concentration was determined to be 2-0 µ / (Silver, Sialyltransferase activity Preliminary studies of sialyltransferase activity in bovine serum were performed to establish optimum conditions for the assay. In particular, incorporation was found to be linear for 1 h and to be linear with sample concentration up to 30 µ serum/100 µ total volume. The concentration of the acceptor asialofetuin in the assay was chosen to be 2-5 mg/ml, since this level gave optimal activity and inhibition of incorporation occurred at concentrations above 4 mg/ml. Average activities ranged from 010 to 016 nmol/h/mg with individual samples from 0-06 to 0-20 nmol/h/mg. These (Table 2 ). In addition to the major peak of activity occurring at Day 12 in treated cows, there was an early rise in sialyltransferase activity, which peaked at Day 2 in control and treated animals. This early peak may be a result of the stress associated with ovariectomy, since elevated values of sialyltransferase may accompany inflammation (Kaplan, Woloski, Hellman & Jamieson, 1983) or tissue regeneration (Van Dijk, Lasthuis, Trippelvite & Muilerman, 1983) . However, the peak in sialyltransferase activity which occurs at Day 12 in treated animals cannot be attributed to the ovariectomy. The difference between values from treated and control animals, which had also been ovariectomized, was significant. Furthermore, preliminary studies of the specificity of the enzyme on Day 12 sera were performed as described by Sherblom & Bourassa (1983) with lactose as the acceptor. The results showed that the enzyme was predominantly a galactose-Ä ( 2->3) sialyltransferase rather than the galactose-/? ( 2-»6) sialyltransferase associated with inflammation (Kaplan et ai, 1983 ) (data not shown).
Discussion
Previous studies have shown that high levels of progesterone (103-104 ng/ml) result in in-vitro immunosuppression of human (Mori et ai, 1975; Clemens et ., 1979) but not bovine (Murray & Chenault, 1982) lymphocytes. In the current work immunosuppression was observed in serum samples in which the circulating progesterone concentration was in the normal physiological range (4-6 ng/ml). The suppression of lymphocyte proliferation appeared to be a function of rising progesterone concentration, because as the progesterone concentration reached a plateau immunosuppressive activity returned to control values (Text- fig. 2 ). The results cannot be due solely to the presence of progesterone in the serum samples, because the effective concentration in the assay is too low (0-1-0-2 ng/ml) to result in immunosuppression, and because samples with the highest levels of progesterone (Days 12 to 36) did not have immunosuppressive activity. Progesterone treatment is known to induce synthesis of immunosuppressive uterine proteins (Roberts, 1977 ; Etzel et ai, 1978) , and the current study suggests that this is a systemic rather than a localized phenomenon.
The immunosuppression observed in progesterone-treated animals appeared to be directed towards rather than lymphocytes, since significant differences were observed with phytohaemagglutinin but not pokeweed mitogen. This is of interest since progesterone itself is thought to suppress specifically proliferation of lymphocytes in vitro (Stites, Bugbee & Siiteri, 1983; . Sialic acid content and sialyltransferase activity were also sensitive to rising levels of progesterone. The increasing sialyltransferase activity and sialic acid content paralleled closely the increasing level of progesterone (compare Text- fig. 3 with Text- fig. 1 fig. 4 ). Second, it is possible that progesterone stimulates synthesis of glycoproteins which are immunosuppressive, but that sialyltransferase activity is a marker for a late phase in the process. In support of this hypothesis is the specificity of the lectin phytohaemagglutinin for galactose residues, which suggests that glycoproteins containing galactose as the terminal sugar will be most effective as immunosuppressants. Completion of the carbohydrate chain by addition of sialic acid to the galactose would be expected to reduce the immunosuppressive activity with phytohaemagglutinin.
Furthermore, studies of rat endometrium have shown that activity of the enzyme galactosyltransferase peaks before that of sialyltransferase during the oestrous cycle (Nelson et ai, 1977 
